Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovary

    Cancer of the ovary confers the worst prognosis among women with gynecological malignancies, primarily because most ovarian cancers are diagnosed at late stage. Hence, there is a substantial need to develop ne...

    Dirk Bauerschlag, Karen Bräutigam in Journal of Cancer Research and Clinical On… (2013)

  2. No Access

    Article

    Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth

    Intravenously-applied bacteria tend to accumulate in tumors and can sporadically lead to tumor regression. Systemic administration of attenuated Salmonella typhimurium is safe and has shown no significant adverse...

    Markus Loeffler, Gaelle Le’Negrate, Maryla Krajewska in Cancer Immunology, Immunotherapy (2009)

  3. No Access

    Article

    BLOC1S2 interacts with the HIPPI protein and sensitizes NCH89 glioblastoma cells to apoptosis

    The HIPPI (HIP-1 protein interactor) protein is a multifunctional protein that is involved in the regulation of apoptosis. The interaction partners of HIPPI include HIP-1 (Huntingtin-interacting protein-1), Ap...

    Georg Gdynia, Judith Lehmann-Koch, Sebastian Sieber, Katrin E. Tagscherer in Apoptosis (2008)

  4. No Access

    Article

    Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetate

    To characterize the stability, pharmacokinetics and metabolism of analogs of gossypol, apogossypol and apogossypol hexaacetate to provide a basis for comparison.

    Lee Jia, Lori C. Coward, Corenna D. Kerstner-Wood in Cancer Chemotherapy and Pharmacology (2008)

  5. No Access

    Article

    Drug Insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms

    Regulation of cell death pathways is pivotal to cancer development and progression. Much knowledge has been gained from basic research efforts to understand the complex molecular mechanisms that drive cell tur...

    John C Reed in Nature Clinical Practice Oncology (2006)

  6. No Access

    Article

    Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential

    Profiles of gene transcription have begun to delineate the molecular basis of ovarian cancer, including distinctions between carcinomas of differing histology, tumor progression and patient outcome. However, t...

    Ivo Meinhold-Heerlein, Dirk Bauerschlag, Felix Hilpert, Petre Dimitrov in Oncogene (2005)

  7. No Access

    Article

    Siah-1L, a novel transcript variant belonging to the human Siah family of proteins, regulates β-catenin activity in a p53-dependent manner

    β-Catenin is a potent oncogenic protein whose cytoplasmic accumulation is a frequent event in cancer cells. The level of β-catenin is regulated by two mechanisms: the adenomatous polyposis coli/Axin/glycogen synt...

    Akio Iwai, Hiroyuki Marusawa, Shu-ichi Matsuzawa, Toru Fukushima in Oncogene (2004)

  8. No Access

    Article

    Heat-shock proteins as regulators of apoptosis

    Heat-shock proteins are produced in response to different types of stress conditions making cells resistant to stress-induced cell damage. Under normal conditions, heat-shock proteins play numerous roles in ce...

    Shinichi Takayama, John C Reed, Sachiko Homma in Oncogene (2003)

  9. No Access

    Article

    Foreword

    John C Reed in Oncogene (2003)

  10. No Access

    Article

    Bcl-2 and Bcl-xL differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24

    Subtraction hybridization identified melanoma differentiation associated gene-7, mda-7, in the context of terminally differentiated human melanoma cells. Based on its structure, cytokine-like properties and propo...

    Irina V Lebedeva, Devanand Sarkar, Zao-Zhong Su, Shinichi Kitada, Paul Dent in Oncogene (2003)

  11. No Access

    Article

    PG490-mediated sensitization of lung cancer cells to Apo2L/TRAIL-induced apoptosis requires activation of ERK2

    Tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) belongs to the family of programmed cell death-inducing cytokines. Apo2L/TRAIL induces apoptosis in a wide variety of tumor cells. Tumor ce...

    Steffen Frese, Farzaneh Pirnia, Daniela Miescher, Stan Krajewski in Oncogene (2003)

  12. No Access

    Article

    Dysregulation of apoptosis genes in hematopoietic malignancies

    Ever since the discovery of Bcl-2 and the elucidation of its role in apoptosis, tremendous interest has arisen in prospects for triggering suicide of malignant cells by exploiting knowledge emerging from apopt...

    Shinichi Kitada, Irene M Pedersen, Aaron D Schimmer, John C Reed in Oncogene (2002)

  13. No Access

    Article

    The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells

    Human melanoma cells growth arrest irreversibly, lose tumorigenic potential and terminally differentiate after treatment with a combination of fibroblast interferon (IFN-β) and the protein kinase C activator m...

    Irina V Lebedeva, Zao-zhung Su, Yonmee Chang, Shinichi Kitada, John C Reed in Oncogene (2002)

  14. No Access

    Article

    Inhibition of the NF-κB transcription factor increases Bax expression in cancer cell lines

    The NF-κB transcription factor has been shown to inhibit apoptosis in several experimental systems. We therefore investigated whether the expression of the Bax proapoptotic protein could be influenced by NF-κB...

    Mohamed Bentires-Alj, Emmanuel Dejardin, Patrick Viatour, Carine Van Lint in Oncogene (2001)

  15. No Access

    Article

    Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator

    Bcl-2 family protein including anti-apoptotic (Bcl-2) or pro-apoptotic (Bax) members can form ion channels when incorporated into synthetic lipid bilayers. This contrasts with the observation that Bcl-2 stabil...

    Catherine Brenner, Hervé Cadiou, Helena LA Vieira, Naoufal Zamzami in Oncogene (2000)

  16. No Access

    Article

    Effect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells

    The cyclin kinase inhibitor p21WAF1/Cip1 is upregulated by the tumor suppressor p53. While p21 is central for the G-1 arrest mediated by p53, it is still unclear if p21 also functions as a downstream effector of ...

    Rati Fotedar, Howard Brickner, Neshat Saadatmandi, Tristan Rousselle in Oncogene (1999)

  17. No Access

    Article

    BAG-1 accelerates cell motility of human gastric cancer cells

    BAG-1 is a Hsp70/Hsc70-binding protein that interacts with Bcl-2, Raf-1, steroid hormone receptors, Siah-1, and hepatocyte growth factor (HGF) receptors, implying multiple functions for the BAG-1 protein. Here...

    Yasuyoshi Naishiro, Masaaki Adachi, Hiroyuki Okuda, Atsushi Yawata in Oncogene (1999)

  18. No Access

    Article

    Bcl-2 Gene Family and Related Proteins in Mammary Gland Involution and Breast Cancer

    The Bcl-2 gene family regulates tissuedevelopment and tissue homeostasis through the interplayof survival and death factors. Family members arecharacterized as either pro-apoptotic or anti-apoptotic, depending...

    Kristel Schorr, Minglin Li in Journal of Mammary Gland Biology and Neopl… (1999)

  19. No Access

    Article

    Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore

    The molecular mode of action of lonidamine, a therapeutic agent employed in cancer chemotherapy, has been elusive. Here we provide evidence that lonidamine (LND) acts on mitochondria to induce apoptosis. LND p...

    Luigi Ravagnan, Isabel Marzo, Paola Costantini, Santos A Susin, Naoufal Zamzami in Oncogene (1999)

  20. No Access

    Article

    Bcl-2 family proteins

    Bcl-2 family proteins serve as critical regulators of pathways involved in apoptosis, acting to either inhibit or promote cell death. Altered expression of these proteins occurs commonly in human cancers, cont...

    John C Reed in Oncogene (1998)

previous disabled Page of 2